~~<i id='93F7A483CA'><strike id='93F7A483CA'><tt id='93F7A483CA'><pre id='93F7A483CA'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

author：explore 2025-09-28 02:31:57 - browse：61823

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： An outrageous hospital charge: I paid $710 for an hour of babysitting

hotspot

focus

Wikipedia

entertainment

focus

hotspot

2:18RepublicanpresidentialcandidateformerU.S.PresidentDonaldTrumpspeaksattheFaithandFreedomRoadtoMaj

WSS

Trump allegedly attempted to have surveillance video deleted: Special Counsel

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

Will biotech layoffs continue through 2023?

The mammogram wars are not over

Biden to sign 'historic' executive order on how US military handles sexual assault cases

STAT Summit: Ending the crisis of Black deaths in the U.S.

explore

explore

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

'The boss' wants server deleted: New allegations emerge in Trump indictment

Apple is now the first public company to be valued at $3 trillion

Biden to sign 'historic' executive order on how US military handles sexual assault cases

Heart attack and stroke risk calculators need revising

Ending health disparities requires full federal government, panel says

DIEP, the 'gold standard' of breast reconstruction, is under threat

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

Virginia high school admissions case could be legal follow

FDA clears Verve to begin U.S. study of gene

focus

Alexander Hamilton and the argument for universal insurance

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Roche drug slashes death risk in early

'The boss' wants server deleted: New allegations emerge in Trump indictment

CZI to create biohub to build anti

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Wikipedia

entertainment

focus

hotspot